Now in its 10th edition, Cell and Gene Therapy World Asia has firmly established itself as Asia’s leading cell and gene therapy gathering for new partnerships, ideas, and knowledge. We are proud to continue providing a platform where Asia’s rapidly growing CGT industry takes center stage, attracting increasing global attention for its fast-paced advancements in new therapies, R&D, and biomanufacturing.
CONCEPT
10 Years of Powering Progress and Shaping the Future of Cell & Gene Therapy
Marking its landmark 10th edition, Cell & Gene Therapy World Asia has become the ultimate platform where the entire CGT ecosystem unites under one roof, from pioneering scientists and visionary leaders to bold innovators driving discoveries through to commercialization. For a decade, this flagship summit has served as the launchpad for breakthroughs, bold ideas, and game-changing collaborations that are accelerating the global CGT revolution. Year after year, it has forged partnerships, ignited innovation, and propelled Asia's CGT industry onto the world stage.
In 2026, we're going bigger, bolder, and further than ever, celebrating a decade of achievement while charting the course for the next.
Join us as the world's leading minds converge to shape the future of cell and gene therapy in Asia and beyond.
Key Themes & Topics
Cell Therapy Innovation: From Discovery to Delivery
Spotlighting the latest breakthroughs and scientific advances driving next-generation cell therapies from early research through to clinical success.
Next-Gen Genetic Medicine & Emerging Modalities
Exploring RNA platforms, synthetic DNA, and other cutting-edge therapeutic technologies transforming the future of medicine.
Smart Manufacturing, Automation & Scale-Up
Addressing the challenges of scaling cell and gene therapies, from process optimization and automation to overcoming manufacturing and regulatory hurdles.
Translational Challenges & Disease Targets
Tackling barriers in translating CGT to the clinic, including solid tumors, rare diseases, and complex therapeutic areas.
Regulatory Pathways & APAC Alignment
Accelerating development through harmonized regulatory frameworks, faster approvals, and cross-border compliance strategies across Asia-Pacific.
Collaboration & Ecosystem Growth
Showcasing strategic partnerships, industry–academia alliances, and collaborative models that are driving innovation and expanding the CGT ecosystem in APAC.
Commercialization & Market Access
Charting the path from R&D to commercialization, including market readiness, reimbursement strategies, and building sustainable business models.
What to Expect at the 10th Annual Cell & Gene Therapy World Asia 2026
Attendees
Join over 300 professionals at the 9th Annual Cell & Gene Therapy World Asia! Connect with key industry players, expand your network, and engage in high-level discussions shaping the future of biologics.
Companies
Meet 100 leading companies driving innovation in the biologics sector. Whether you're seeking new partners or exploring the latest breakthroughs, this is the ideal platform to discover what’s next in the industry.
Speakers
Gain exclusive insights from 50 expert speakers shaping the future of biologics. Learn from the best in the field as they share cutting-edge knowledge, practical solutions, and emerging trends you won’t want to miss.
Networking Hours
Case Studies
Testimonials
“Thank you for impactful events arranged for Korean attendees and giving us opportunities to have meaningful discussion with customers.”
West Pharmaceutical Services Korea
“Thank you for impactful events arranged for Korean attendees and giving us opportunities to have meaningful discussion with customers.”
West Pharmaceutical Services Korea
“Thank you for impactful events arranged for Korean attendees and giving us opportunities to have meaningful discussion with customers.”
West Pharmaceutical Services Korea
“Thank you for impactful events arranged for Korean attendees and giving us opportunities to have meaningful discussion with customers.”
West Pharmaceutical Services Korea
WHO
C-suites, Presidents, VP’s, Directors, and Heads of R&D, Process Development, Manufacturing, Cell & Gene Therapy, Regenerative Medicine, Quality Control & Assurance and Regulatory Affairs from cell and gene therapy companies across Asia and globally.
WHAT
Evaluate and adopt the most effective strategies, technologies and operational models to fast-track high-quality cell and gene therapies from discovery through clinical trials to commercial launch across Asia.
WHY
Asia-Pacific is rapidly becoming a powerhouse in the global cell & gene therapy field. Recent forecasts indicate that the APAC biomanufacturing segment will expand from approximately US$2.0 billion in 2022 to around US$8.6 billion by 2031. Meanwhile, the overall CGT market in the region comprising therapeutics, novel modalities, and supporting services is expected to rise from just over US$1.0 billion in 2023 to more than US$8.0 billion by 2031. Strong investment, regulatory alignment, and breakthroughs in genetic medicine are fuelling this growth, making this a pivotal moment to be part of Asia's fast-advancing CGT revolution.
CONTACT
Ana Laxamana, Business Development Manager
m: +65 6983 6132
Nathan Grace Niño, Business Development Manager
m: +65 6983 6134 | +44 161 552 8521
Share With Your Network
